Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 272 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q2
EMD SERONO, INC. for EMD SERONO INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q2
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code
View →
Q2
PFIZER INC. for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
AVOQ, LLC for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q2
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues
View →
Q2
SPLITOAK STRATEGIES LLC for JOHNSON & JOHNSON SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q2
SPLITOAK STRATEGIES LLC for BRISTOL-MYERS SQUIBB
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Medicare/Medicaid
View →
Q2
SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q2
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q2
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q2
SPLITOAK STRATEGIES LLC for CHIESI USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · North Carolina · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
AVENUE SOLUTIONS for MODERNA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View →
Q2
AVENUE SOLUTIONS for MERCK & CO. INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Agriculture, Animals, Budget/Appropriations
View →
Q2
AVENUE SOLUTIONS for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
AVENUE SOLUTIONS for GENENTECH USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
TARPLIN, DOWNS & YOUNG, LLC for JAZZ PHARMACEUTICALS INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $80,000.00 income
Health Issues
View →
Q2
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
Previous Page 7 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem